☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Regimen
Sanofi's Sarclisa Combination Regimen Receives Health Canada's Approval for Multiple Myeloma
October 13, 2021
Celltrion Report Results of Truxima (biosimilar- rituximab) Based Regimen in P-II Study for R/R Aggressive B-cell Lymphoma #EHA25
June 16, 2020
Celltrion and MSD Report Results of First-Line Triplet Regimen P-I/II PANTHERA trial in Patients with HER2-Positive Advanced Gastr...
May 27, 2020
QIAGEN Launches Therascreen BRAF Test as CDx to a BraftovI Regimen for Metastatic Colorectal Cancer
April 16, 2020
Janssen's Darzalex (daratumumab) Combination Regimen Receives Health Canada Approval for Transplant Ineligible Patients with Multi...
October 31, 2019
Merck Receives EU's CHMP Positive Opinion for its Zerbaxa (ceftolozane and tazobactam) and Keytruda (pembrolizumab) + Inlyta (axit...
July 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.